Archives

Shields Outcomes 2024 Report 70 70 Shields Health Solutions

Shields Outcomes 2024 Report
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

This poster evaluates the clinical and quality outcomes of a bleeding disorder program at a health system HSSP.

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation 216 115 Shields Health Solutions

Establishing Proportion of Days Covered Benchmarks for Health System Specialty Pharmacy Clinical Outcomes Evaluation

This poster aims to establish goals for a dashboard displaying medication adherence by disease state and PDC thresholds through a comprehensive literature review, validating the existing targets.

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy on Clinical and Operational Outcomes in Cystic Fibrosis Patients

This poster explores the impact of a Health System Specialty Pharmacy care model paired with a pharmacist-led CDTM program on CF patient outcomes.

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients 204 115 Shields Health Solutions

How Health System Specialty Pharmacy Can Support Pediatric Diabetes Patients
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services 204 115 Shields Health Solutions

How Spartanburg Regional Healthcare System Increased Patient Satisfaction by 24% with Specialty Pharmacy Services
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Shields Health Solutions and Sutter Health Expand Collaboration to Enhance Patient Access to Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and Sutter Health Expand Collaboration to Enhance Patient Access to Specialty Pharmacy Services

STOUGHTON, Mass. & SACRAMENTO, Calif.—(BUSINESS WIRE)—Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the United States and a Walgreens-owned company, has expanded its work with Sutter Health, one…

Exploring AI’s Potential to Transform Specialty Pharmacy 204 115 Shields Health Solutions

Exploring AI’s Potential to Transform Specialty Pharmacy
This white paper explores the opportunities and unknowns that health organizations must consider when weighing the implementation of AI.
Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population 216 115 Shields Health Solutions

Impact of an Integrated Health System Specialty Pharmacy Liaison-Managed Care Model within an Uncontrolled Diabetes Population

This poster explores the impact of the pharmacy liaison-managed care model at CHRISTUS Health System on HbA1c reduction and medication adherence for patients living with diabetes with baseline A1C>9.

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services 204 115 Shields Health Solutions

Shields Health Solutions and UnityPoint at Home Extend Collaboration, Providing Patients and Families Enhanced Specialty Pharmacy Services
Shields and UnityPoint at Home have expanded their partnership providing patients with complex, chronic conditions access to specialized pharmacy services designed to lower costs, broaden treatment options, enhance medication management, and improve overall health.